Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, interferon and immune responses, Immune Cell Function and Interaction, and Immunotherapy and Immune Responses.
Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Innate Immune Recognition of Cancer
The STING pathway and the T cell-inflamed tumor microenvironment
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Type I interferon response and innate immune sensing of cancer
Innate immune sensing of cancer: clues from an identified role for type I IFNs